Henry Schein, Inc. (NASDAQ:HSIC) Shares Bought by Natixis Advisors LLC

Natixis Advisors LLC lifted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 5.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,508 shares of the company’s stock after acquiring an additional 572 shares during the period. Natixis Advisors LLC’s holdings in Henry Schein were worth $788,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the business. Palestra Capital Management LLC acquired a new stake in shares of Henry Schein in the fourth quarter worth $182,988,000. Fiduciary Management Inc. WI increased its position in shares of Henry Schein by 7.2% in the fourth quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company’s stock worth $172,193,000 after acquiring an additional 167,990 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Henry Schein by 15.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,137,549 shares of the company’s stock valued at $147,920,000 after purchasing an additional 279,507 shares in the last quarter. Steadfast Capital Management LP grew its holdings in Henry Schein by 254.2% during the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company’s stock valued at $113,336,000 after purchasing an additional 1,175,408 shares in the last quarter. Finally, Hudson Bay Capital Management LP grew its holdings in Henry Schein by 102.1% during the 4th quarter. Hudson Bay Capital Management LP now owns 1,465,007 shares of the company’s stock valued at $101,378,000 after purchasing an additional 740,007 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of HSIC stock opened at $65.94 on Monday. The firm has a market cap of $8.00 billion, a P/E ratio of 21.27, a P/E/G ratio of 2.17 and a beta of 0.81. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The firm has a fifty day moving average of $71.07 and a two-hundred day moving average of $71.06.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. During the same period last year, the firm posted $1.23 earnings per share. The company’s quarterly revenue was up 3.3% on a year-over-year basis. As a group, research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analyst Ratings Changes

HSIC has been the subject of a number of recent analyst reports. Wells Fargo & Company lowered their price target on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a report on Tuesday, May 6th. Stifel Nicolaus reaffirmed a “hold” rating and set a $75.00 price target (down from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Wall Street Zen lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Piper Sandler lowered their price target on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a report on Wednesday, April 30th. Finally, Baird R W lowered shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a report on Monday, July 14th. Nine analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $75.58.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.